Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioma 3Glioblastoma 2Recurrence 1Optic Nerve Glioma 1Oligodendroglioma 1Neoplasms, Neuroepithelial 1Gliosarcoma 1Ependymoma 1Brain Neoplasms 1Astrocytoma 1

Interventions

palbociclib 1fluorodopa F 18 1fludarabine phosphate 1fludarabine 1Thiotepa 1Tacrolimus 1Mycophenolic Acid 1Melphalan 1Magnetic Resonance Spectroscopy 1Fibroblast Growth Factor 7 1Etoposide 1Doxorubicin 1Dexamethasone 1Cyproheptadine 1Cyclosporins 1Cyclosporine 1Calcium Dobesilate 1Alemtuzumab 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Neoplasms, Neuroepithelial × fluorodopa F 18 × Clear all
NCT02175745 2017-03-20

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Stanford University

Phase NA Terminated
2 enrolled 7 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Neoplasms, Neuroepithelial, Gliosarcoma, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡